Zydus Lifesciences gets USFDA nod to sell generic anti-epileptic medication
Zydus Lifesciences Received approva to manufacture and market Lacosamide Tablets in multiple strengths Zydus Lifesciences on Saturday said it
Continue readingThe Number One Finance & Business Blog!
Zydus Lifesciences Received approva to manufacture and market Lacosamide Tablets in multiple strengths Zydus Lifesciences on Saturday said it
Continue readingThe US health regulator has pulled up Intas Pharmaceuticals for manufacturing lapses, including violation of current good manufacturing practice
Continue readingAurobindo Pharma Ltd’s shares were up by 0.50 per cent following the company’s announcement of receiving final approval from the
Continue readingNew Jersey-based and wholly-owned subsidiary of Aurobindo Pharma USA, Acrotech Biopharma, and Evive Biotech, a biopharmaceutical company and subsidiary of
Continue readingPharmaceutical giant Cipla has received a warning letter from the United States Food and Drug Administration (USFDA) as part
Continue readingGland Pharma Ltd has received approval from the United States Food and Drug Administration (US FDA) for Angiotensin II Injection,
Continue readingTarget: ₹1,305 CMP: ₹1,140.75 Sun Pharmaceutical’s Q2 performance was in line with JMF/ Street estimates. Revenue growth was led by
Continue readingGranules India Limited announced that the USFDA approved its Abbreviated New Drug Application (ANDA) for Esomeprazole Magnesium Delayed-Release Capsules USP,
Continue readingThe USFDA has “determined the inspection classification as ‘OAI’ (Official Action Indicated). The OAI status may cause delay and/or withholding
Continue readingLeading drug makers Sun Pharmaceutical Industries and Aurobindo Pharma are recalling products from the US market due to manufacturing
Continue reading